Cargando…
Operational Strategies for Clinical Trials in Africa
PURPOSE: In a dramatic reversal of longstanding trends, cancer now kills more Africans than malaria. Despite Africa’s growing cancer burden, individuals of African descent, notably those residing in Africa, remain drastically under-represented in cancer clinical trials. Two recent summits—the 1st Al...
Autores principales: | Graef, Katy M., Okoye, Ifeoma, Ohene Oti, Naomi O., Dent, Jennifer, Odedina, Folakemi T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392738/ https://www.ncbi.nlm.nih.gov/pubmed/32614727 http://dx.doi.org/10.1200/JGO.19.00204 |
Ejemplares similares
-
Oncology Clinical Trials in Africa: Emerging and Operational Issues
por: Odedina, Folakemi T., et al.
Publicado: (2020) -
SWOT Analysis of Oncology Clinical Trials in Africa: A Town Hall Report From the Global Congress on Oncology Clinical Trials in Blacks
por: Ezeani, Adaora, et al.
Publicado: (2019) -
Landscape of Oncology Clinical Trials in Africa
por: Odedina, Folakemi T., et al.
Publicado: (2020) -
Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop
por: Kizub, Darya, et al.
Publicado: (2022) -
Oncology Clinical Trials in Africa: Partnering for Quality
por: Shamley, Delva, et al.
Publicado: (2021)